-
(-)-Blebbistatin: Reliable Cytoskeletal Assays
2026-09-15
Learn how (-)-Blebbistatin (SKU B1387) can help distinguish actomyosin-dependent changes from nonspecific toxicity in viability, proliferation, and mechanobiology workflows. This scenario-driven guide covers mechanism, dosing, controls, interpretation, and practical vendor-selection criteria.
-
SIRT4–GDH Axis in Liver Fibrosis
2026-09-15
The reference study identifies a metabolic mechanism in which reduced SIRT4 activity permits GDH-dependent glutamine catabolism in hepatic stellate cells, supporting α-ketoglutarate production, proliferation, and fibrotic progression. Pharmacological GDH inhibition and SIRT4 overexpression each produced antifibrotic effects in cellular and animal experiments, positioning glutamine metabolism as a potential therapeutic target.
-
Spirocyclic POM Analogues Target MmpL3 in TB
2026-09-14
This 2024 Bioorganic Chemistry study develops spirocyclic phenyl oxazole methyl derivatives as MmpL3-directed anti-tuberculosis candidates. Compound 5c combined submicromolar activity against Mycobacterium tuberculosis with activity against drug-resistant clinical isolates, acceptable preliminary ADME and pharmacokinetic properties, and low cytotoxicity in THP-1 cells.
-
PHF2, Neuroinflammation, and Alzheimer’s Disease
2026-09-14
A 2025 Molecular Psychiatry study identifies the histone demethylase PHF2 as an upstream regulator of inflammatory gene expression in Alzheimer’s disease. Using human tissue, patient-derived neurons, ChIP-seq, genetic perturbation, and a 5xFAD mouse model, the authors connect PHF2 reduction with lower glial activation, improved synaptic function, and better spatial memory.
-
BMS-777607 for MET Signaling and Platelet Research
2026-09-13
BMS-777607 supports controlled MET-family pathway perturbation in cancer metastasis models and exploratory hiPSC-derived megakaryocyte studies. This guide connects phospho-MET assays, platelet differentiation workflows, dose handling, and troubleshooting without overstating evidence from either research domain.
-
Nonselective β-Blockade and HCT Engraftment
2026-09-12
This study shows that nonselective β-adrenergic receptor inhibition can impair hematopoietic regeneration after transplantation, whereas β1-selective inhibition has a substantially different effect. Mouse experiments and human cohort analyses connect the finding to allogeneic transplantation, posttransplant chemotherapy, platelet engraftment, survival, and hematopoietic cell dose.
-
RNA Clean and Concentrator Kit for IVT RNA
2026-09-12
Build a cleaner path from enzymatic RNA synthesis to LNP formulation, RT-qPCR, and cell-based assays with a rapid membrane workflow. This guide shows how the RNA Clean and Concentrator Kit supports high-throughput cleanup while addressing size selection, salt carryover, low yield, and translation-readiness.
-
EdU Flow Cytometry Assay Kits (Cy5): Practical Guide
2026-09-11
Learn how to use EdU Flow Cytometry Assay Kits (Cy5) for direct S-phase DNA synthesis measurement in tumor, immune, and drug-response models. This workflow combines click chemistry specificity, far-red Cy5 detection, and multiplex-compatible sample handling to improve proliferation data quality.
-
TH287 Radiosensitizes Castration-Resistant Prostate Cancer
2026-09-11
A 2026 study found that TH287, an MTH1 inhibitor, enhanced ionizing-radiation responses in PC-3 and DU-145 castration-resistant prostate cancer cells. The strongest combination effect occurred when radiation was delivered 12 hours after TH287 exposure, with reduced survival, increased apoptosis, and cell-cycle disruption.
-
Sulfamonomethoxine Workflows for Veterinary Research
2026-09-10
Sulfamonomethoxine supports controlled antibacterial, antiprotozoal, aquaculture, and environmental workflows when solvent behavior and assay context are managed carefully. This guide translates stratified veterinary susceptibility methods into practical SMM testing, degradation studies, and troubleshooting strategies.
-
Epigenetic MCL-1 Targeting in Glioblastoma
2026-09-10
The reference study identifies a super-enhancer near Mcl-1 as a transcriptional vulnerability in glioblastoma and shows that THZ1-mediated MCL-1 suppression sensitizes tumors to BCL-2/BCL-XL inhibition. Its chromatin, mitochondrial apoptosis, and patient-derived xenograft data support a context-dependent synthetic-lethal strategy while highlighting important limits for translation.
-
Dhcr7 Knockout Grass Carp Resists GCRV
2026-09-09
A 2026 Aquaculture Reports study used CRISPR/Cas9 and an in vivo GCRV-II challenge to validate Dhcr7 as a molecular target for disease-resistant grass carp breeding. Dhcr7-disrupted fish showed higher survival, stronger Irf3-associated antiviral responses, lower viral burden, and reduced hepatopancreas injury without detectable effects on measured growth or muscle morphology.
-
Cisplatin (CDDP): DNA Damage Workflows
2026-09-09
Build more interpretable Cisplatin experiments by separating DNA damage, pathway adaptation, and cell death readouts. This workflow connects CDDP-based apoptosis assays and xenograft studies with the Wnt–EGFR DNA-damage framework described in Drosophila, while offering practical preparation, optimization, and troubleshooting guidance.
-
Coumestrol in RA-FLS Ferroptosis Research
2026-09-08
Coumestrol connects estrogen receptor pharmacology with a practical ferroptosis workflow in rheumatoid arthritis fibroblast-like synoviocytes. This guide translates the TRIM3–PMAIP1 finding into assay design, formulation control, mechanistic validation, and troubleshooting decisions.
-
740 Y-P for PI3K/AKT Assay Design
2026-09-08
Use 740 Y-P as a cell-permeable PI 3-kinase activator to connect PI3K signaling with survival, vesicular trafficking, and mitophagy phenotypes. This practical guide translates chondrocyte pyroptosis findings into controlled workflows for cancer research, neuronal cell survival, and pathway-validation experiments.